244 related articles for article (PubMed ID: 10815905)
1. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer.
Tanner MM; Grenman S; Koul A; Johannsson O; Meltzer P; Pejovic T; Borg A; Isola JJ
Clin Cancer Res; 2000 May; 6(5):1833-9. PubMed ID: 10815905
[TBL] [Abstract][Full Text] [Related]
2. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.
Bautista S; Vallès H; Walker RL; Anzick S; Zeillinger R; Meltzer P; Theillet C
Clin Cancer Res; 1998 Dec; 4(12):2925-9. PubMed ID: 9865902
[TBL] [Abstract][Full Text] [Related]
3. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.
Tanner MM; Tirkkonen M; Kallioniemi A; Isola J; Kuukasjärvi T; Collins C; Kowbel D; Guan XY; Trent J; Gray JW; Meltzer P; Kallioniemi OP
Cancer Res; 1996 Aug; 56(15):3441-5. PubMed ID: 8758909
[TBL] [Abstract][Full Text] [Related]
4. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas.
Sonoda G; Palazzo J; du Manoir S; Godwin AK; Feder M; Yakushiji M; Testa JR
Genes Chromosomes Cancer; 1997 Dec; 20(4):320-8. PubMed ID: 9408747
[TBL] [Abstract][Full Text] [Related]
5. Prognosis and gene expression profiling of 20q13-amplified breast cancers.
Ginestier C; Cervera N; Finetti P; Esteyries S; Esterni B; Adélaïde J; Xerri L; Viens P; Jacquemier J; Charafe-Jauffret E; Chaffanet M; Birnbaum D; Bertucci F
Clin Cancer Res; 2006 Aug; 12(15):4533-44. PubMed ID: 16899599
[TBL] [Abstract][Full Text] [Related]
6. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications.
Tanner MM; Tirkkonen M; Kallioniemi A; Holli K; Collins C; Kowbel D; Gray JW; Kallioniemi OP; Isola J
Clin Cancer Res; 1995 Dec; 1(12):1455-61. PubMed ID: 9815944
[TBL] [Abstract][Full Text] [Related]
7. The role of protein elongation factor eEF1A2 in ovarian cancer.
Lee JM
Reprod Biol Endocrinol; 2003 Oct; 1():69. PubMed ID: 14588074
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
[TBL] [Abstract][Full Text] [Related]
9. [Oncogene ZNF217 amplification on chromosome 20 q in ovarian serous cystadenocarcinoma and its clinical implications].
Li J; Zhong M; Song LL; Su GD
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):824-5. PubMed ID: 16793610
[TBL] [Abstract][Full Text] [Related]
10. Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer.
Guan XY; Xu J; Anzick SL; Zhang H; Trent JM; Meltzer PS
Cancer Res; 1996 Aug; 56(15):3446-50. PubMed ID: 8758910
[TBL] [Abstract][Full Text] [Related]
11. The human ovarian teratocarcinoma cell line PA-1 demonstrates a single translocation: analysis with fluorescence in situ hybridization, spectral karyotyping, and bacterial artificial chromosome microarray.
Sarraf S; Tejada R; Abawi M; Oberst M; Dennis T; Simon KC; Blancato J
Cancer Genet Cytogenet; 2005 Aug; 161(1):63-9. PubMed ID: 16080959
[TBL] [Abstract][Full Text] [Related]
12. Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers.
Watanabe T; Imoto I; Katahira T; Hirasawa A; Ishiwata I; Emi M; Takayama M; Sato A; Inazawa J
Jpn J Cancer Res; 2002 Oct; 93(10):1114-22. PubMed ID: 12417041
[TBL] [Abstract][Full Text] [Related]
13. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
[TBL] [Abstract][Full Text] [Related]
14. Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.
Bièche I; Tomasetto C; Régnier CH; Moog-Lutz C; Rio MC; Lidereau R
Cancer Res; 1996 Sep; 56(17):3886-90. PubMed ID: 8752152
[TBL] [Abstract][Full Text] [Related]
15. Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection.
Guan XY; Meltzer PS; Dalton WS; Trent JM
Nat Genet; 1994 Oct; 8(2):155-61. PubMed ID: 7842014
[TBL] [Abstract][Full Text] [Related]
16. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A
Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525
[TBL] [Abstract][Full Text] [Related]
17. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
[TBL] [Abstract][Full Text] [Related]
18. [ZNF217 gene was detected in ovarian serous cystadenocarcinoma by fluorescence in situ hybridization].
Zhong M; Li J; Ding YQ; Song LL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):665-7. PubMed ID: 17160949
[TBL] [Abstract][Full Text] [Related]
19. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer.
Mahlamäki EH; Bärlund M; Tanner M; Gorunova L; Höglund M; Karhu R; Kallioniemi A
Genes Chromosomes Cancer; 2002 Dec; 35(4):353-8. PubMed ID: 12378529
[TBL] [Abstract][Full Text] [Related]
20. Amplification and overexpression of aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells.
Chung CM; Man C; Jin Y; Jin C; Guan XY; Wang Q; Wan TS; Cheung AL; Tsao SW
Mol Carcinog; 2005 Jul; 43(3):165-74. PubMed ID: 15880741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
